Xencor Inc

Xencor Inc., established in 1997 and headquartered in Monrovia, California, is a biotechnology firm that specializes in engineering monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. The company's operations are concentrated in research and development of monoclonal antibody therapies. Xencor's drug candidates do not have conventional brand names but are identified by alphanumeric codes like XmAb24306 or XmAb7195, representing various therapeutic antibodies in development. While focusing on the United States market, Xencor's collaborative efforts with international pharmaceutical and biotech entities suggest the potential for an expanded global presence, contingent on clinical advancement and regulatory approvals. (Powered by AI)